Skip to main content

Advertisement

SpringerLink
Log in

Pars plana vitrectomy for treatment of advanced Coats’ disease—presentation of a modified surgical technique and long-term follow-up

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

To present a modified surgical technique in the treatment of retinal detachment secondary to advanced Coats’ disease in children, and report on long-term anatomical and functional outcome.

Methods

We analysed an interventional case series of 13 patients (13 eyes) with advanced Coats’ disease characterised by retinal detachment in addition to massive subretinal exudates and vascular malformation. The presented patients underwent pars plana vitrectomy (PPV), including a modified technique of exocryotherapy applied after fluid–air exchange in order to achieve complete treatment of the vascular changes, to reduce associated side-effects, and to avoid retinectomy and silicone oil tamponade.

Results

Within a median follow-up period of 37 months (range: 18–66 months), no enucleation was necessary. Four eyes (31 %) did not need any further therapy, and in nine eyes (69 %) additional treatments were performed. Six patients (46 %) required revisional surgery with silicone oil tamponade. In ten eyes (77 %), the pathologic vessels and exudates finally regressed and the retina reattached. Visual acuity (VA) could be stabilized in the majority of patients: in three eyes (27 %) VA improved, in four eyes (36 %) VA remained stable, in four eyes (36 %) visual acuity (VA) deteriorated, and in two eyes VA could not be evaluated.

Conclusions

The presented modified technique allows for sufficient cryotherapy of vascular malformations, even in the presence of massive exudation, in a subset of patients with advanced Coats’ disease, and thus may reduce surgery-related complications and improve the rehabilitation process of these young patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Coats G (1908) Forms of retinal diseases with massive exudation. R Lond Ophthalmol Hosp Rep 17:440–525

    Google Scholar 

  2. Shields JA, Shields CL, Honovar SG, Demirci H (2001) Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford memorial lecture. Am J Ophthalmol 131:561–571

    Article  CAS  PubMed  Google Scholar 

  3. Silodor SW, Augsburger JJ, Shields JA, Tasman W (1988) Natural history and management of advanced Coats’ disease. Ophthalmic Surg 19:89–93

    CAS  PubMed  Google Scholar 

  4. Shields JA, Shields CL, Honovar SG, Demirci H, Cater J (2000) Classification and management of Coats’ disease: the 2000 Proctor Lecture. Am J Ophthalmol 131:572–583

    Article  Google Scholar 

  5. Shields JA, Shields CL (2001) Review: Coats disease. The 2001 LuEsther T. Mertz lecture. Retina 22:80–91

    Article  Google Scholar 

  6. Krause L, Kreusel K-M, Jandeck C, Kellner U, Foerster MH (2001) Vitrektomie bei fortgeschrittenem Morbus Coats. Ophthalmologe 98:387–390

    Article  CAS  PubMed  Google Scholar 

  7. Kranias G, Krebs TP (2002) Advanced Coats’ disease successfully managed with vitreo-retinal surgery. Eye 16:500–501

    Article  CAS  PubMed  Google Scholar 

  8. Muftuoglu G, Gulkilik G (2011) Pars plana vitrectomy in advanced Coats’ disease. Case Rep Ophthalmol 2:15–22

    Article  PubMed Central  PubMed  Google Scholar 

  9. Mrejen S, Metge F, Denion E, Dureau P, Edelson C, Capuot G (2008) Management of retinal detachment in Coats' disease. Study of 15 cases. Retina 28:S26–S32

    Article  PubMed  Google Scholar 

  10. Yoshizumi MO, Kreiger AE, Lewis H, Foxman B, Hakakha B (1995) Vitrectomy techniques in late-stage Coats'-like exudative retinal detachment. Doc Ophthalmol 90:387–394

    Article  CAS  PubMed  Google Scholar 

  11. Sterigiou PK, Symeonidis C, Dimitrakos SA (2009) Coats’ disease: treatment with intravitreal bevacizumab and laser photocoagulation. Acta Ophthalmol (Copenh) 87:687–688

    Article  Google Scholar 

  12. Cackett P, Wong D, Cheung CMG (2010) Combined intravitreal bevacizumab and argon laser treatment for Coats’ disease. Acta Ophthalmol (Copenh) 88:e48–e49

    Article  Google Scholar 

  13. Entezari, Ramezani A, Safavizadeh L, Bassimia N (2010) Resolution of macular edema in Coats’ disease with intravitreal bevacizumab. Indian J Ophthalmol 58:80–82

    Article  PubMed Central  PubMed  Google Scholar 

  14. Kaul S, Uparkar M, Mody K, Walinjkar J, Kothari M, Natarajan S (2010) Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats’ disease in children. Indian J Ophthalmol 58:76–78

    Article  PubMed Central  PubMed  Google Scholar 

  15. Böhm MRR, Uhlig CE (2011) Use of intravitreal triamcinolone and bevacizumab in Coats’ disease with central macular edema. Graefes Arch Clin Exp Ophthalmol 249:1099–1101

    Article  PubMed  Google Scholar 

  16. Zhao T, Wang K, Ma Y, Jiang Y-R (2011) Resolution of total retinal detachment in Coats’ disease with intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol 249:1745–1746

    Article  PubMed  Google Scholar 

  17. Ghazi NG, Al Shamsi H, Larsson J, Abboud E (2012) Intravitreal triamcinolone in Coats’ disease. Ophthalmology 119:648–649

    Article  PubMed  Google Scholar 

  18. Zheng X-X, Jiang Y-R (2013) The effect of intravitreal bevacizumab injection as the initial treatment for Coats’ disease. Graefes Arch Clin Exp Ophthalmol Jul 20 [Epub ahead of print]. doi:10.1007/s00417-013-2409-1

    Google Scholar 

  19. Ray R, Barañano DE, Hubbard GB (2013) Treatment of Coats’ disease with intravitreal bevacizumab. Br J Ophthalmol 97:272–277

    Article  PubMed  Google Scholar 

  20. Shields JA, Shields CL (2001) Differentiation of Coats’ disease and retinoblastoma. J Pediatr Ophthalmol Strabismus 38:262–266

    CAS  PubMed  Google Scholar 

  21. Shields CL, Schoenberg E, Kocher K, Shukla SY, Kaliki S, Shields JA (2013) Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases. Results based on age at presentation. Ophthalmology 120:311–316

    Article  PubMed  Google Scholar 

  22. Nagasaki H, Shinagawa K, Mochizuki M (1998) Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 17:77–98

    Article  CAS  PubMed  Google Scholar 

  23. Singh AK, Michels RG, Glaser BM (1986) Scleral indentation following cryotherapy and repeat cryotherapy enhance release of viable retinal epithelial cells. Retina 6:176–178

    CAS  PubMed  Google Scholar 

  24. Lee JH, Kim SJ, Chung H (1995) The effect of subtenon injection of methylprednisolone acetate on the breakdown of blood retinal barrier after cryotherapy. Korean J Ophthalmol 9:1–6

    PubMed  Google Scholar 

  25. Theodossiadis GP (1974) Some clinical, fluorescein-angiographic, and therapeutic aspects of Coats’ disease. J Pediatr Ophthalmol Strabismus 16:257–262

    Google Scholar 

  26. Shapiro MJ, Show CC, Karth PA, Kiernan DF, Blair MP (2011) Effects of green diode laser in the treatment of pediatric Coats' disease. Am J Ophthalmol 151:725–731

    Article  PubMed  Google Scholar 

  27. Schefler AC, Berrocal A, Murray T (2008) Advanced Coats’ disease. Management with repetitive aggressive laser ablation therapy. Retina 28:S38–S41

    Article  PubMed  Google Scholar 

  28. Kirath H, Eldem B (1998) Management of moderate to advanced Coats’ disease. Ophthalmologica 212:19–22

    Article  Google Scholar 

  29. Mulvihill A, Morris B (2010) A population-based study of Coats' disease in the United Kingdom II: investigation, treatment, and outcomes. Eye 24:1802–1807

    Article  CAS  PubMed  Google Scholar 

  30. Ramasubramanian A, Shields CL (2012) Bevacizumab for Coats’ disease with exudative retinal detachment and risk of vitreoretinal traction. Br J Ophthalmol 96:356–359

    Article  PubMed  Google Scholar 

  31. Char DH (2000) Coats’ syndrome: long-term follow-up. Br J Ophthalmol 84:37–39

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no financial interests related to the manuscript.

Author information

Authors and Affiliations

  1. Center for Ophthalmology, Eberhard-Karls-University of Tuebingen, Schleichstr. 12-16, 72076, Tuebingen, Germany

    Daniela Suesskind, Elke Altpeter, Merle Schrader, Karl U. Bartz-Schmidt & Sabine Aisenbrey

Authors
  1. Daniela Suesskind
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elke Altpeter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Merle Schrader
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karl U. Bartz-Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sabine Aisenbrey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniela Suesskind.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suesskind, D., Altpeter, E., Schrader, M. et al. Pars plana vitrectomy for treatment of advanced Coats’ disease—presentation of a modified surgical technique and long-term follow-up. Graefes Arch Clin Exp Ophthalmol 252, 873–879 (2014). https://doi.org/10.1007/s00417-013-2512-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-013-2512-3

Keywords

Search

Navigation